Skip to content

A 12-week Field Trial of the Movámonos Physical Activity Support Program

Movámonos: Translation and Cultural Adaptation of a Theory-Based Physical Activity Support Program for Spanish-Speaking Adults - Aim 2

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07561996
Acronym
Movámonos
Enrollment
20
Registered
2026-05-01
Start date
2026-05-15
Completion date
2027-07-31
Last updated
2026-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obese Adults, Physical Inactivity

Brief summary

The objective of this study is to design and refine an activity support program, called Movámonos, for adults with overweight or obesity who speak Spanish. The primary outcomes are feasibility and acceptability of the Movámonos physical activity support program.

Detailed description

The purpose of this study is to pilot test a 12-week physical activity support program, called Movámonos, designed for Spanish-speaking adults with overweight or obesity. Movámonos includes four intervention components: 1) weekly 60-minute group-based classes, 2) 3, 45-minute individualized support sessions, 3) group fitness classes, and 4) mental guided imagery sessions. Participants will be asked to build their physical activity levels up to 150 minutes/week. The primary outcome is to evaluate the program's acceptability and feasibility from the participant perspective.

Interventions

BEHAVIORALMovámonos Physical Activity Support Program

The 12-week Movámonos program includes four intervention components: 1) weekly, 60-minute group-based classes, 2) 3, 45-minute individualized support sessions, 3) group fitness classes, and 4) weekly mental guided imagery sessions. Participants will be asked to build up their physical activity levels up to 150 minutes/week.

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and Women * Age 18-65 years * Speak Spanish as their primary language * Self-identify as Hispanic or Latino * Body Mass Index 25-45 kg/m2 * Insufficiently active (defined as \<150 min/week of voluntary exercise at moderate intensity over the past 3 months) * Willing not to enroll in any other formal weight loss, physical activity program, or fitness center membership over the next 6 months. * Capable and willing to give informed consent, understand

Exclusion criteria

, attend the Movámonos program sessions, and complete outcome measures. * Able to provide signed physician clearance for exercise if indicated by the Physical Activity Readiness Questionnaire (PAR-Q+) and determined by the study PI.

Design outcomes

Primary

MeasureTime frameDescription
Program Acceptability - Qualitative3 monthsAcceptability of the physical activity support program will be assessed with results of the semi-structured focus groups or interviews from the participant perspective.
Program Feasibility - Qualitative3 monthsFeasibility of the physical activity support program will be assessed with results of the semi-structured focus groups or interviews from the participant perspective.

Secondary

MeasureTime frameDescription
Program Acceptability - Quantitative3 monthsAcceptability of the physical activity support program components will be assessed using the Acceptability of Intervention Measure (AIM) from the participant perspective. Scores range from 0 to 5, with higher scores indicating a better outcome.
Program Feasibility - Quantitative3 monthsFeasibility of the physical activity support program will be assessed using the Feasibility of Intervention Measure (FIM). Scores range from 0 to 5, with higher scores indicating a better outcome.

Contacts

CONTACTDanielle Ostendorf, PhD
dostendo@utk.edu18659748606
CONTACTRyan Marker, PhD, PT
ryan.marker@cuanschutz.edu1303-724-0819

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 2, 2026